country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

SCCPDH - saccharopine dehydrogenase (putative) Gene

Also Known as NET11; CGI-49

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 51097

About SCCPDH

This gene has 1 transcript (splice variant) and 216 orthologues. Broad expression in testis (RPKM 87.1), liver (RPKM 34.8) and 22 other tissues.

Summary

Predicted to enable oxidoreductase activity. Predicted to be involved in glycolipid biosynthetic process. Located in lipid droplet and midbody. [provided by Alliance of Genome Resources, Apr 2022]

SCCPDH Products (1)

mRNA	Protein	Name
NM_016002.3	NP_057086.2	saccharopine dehydrogenase-like oxidoreductase

Gene Ontology

Cellular Component

Cellular Component GO Annotation	Evidence	References	Source
located in lipid droplet	IDA IDA: Inferred from direct assay	14741744	GOA
located in midbody	IDA IDA: Inferred from direct assay	15166316	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

SCCPDH Protein Structure

Sacchrp_dh_NADP

0
100
200
300
400
429 a.a.

Protein Preferred Names	Protein Names
saccharopine dehydrogenase-like oxidoreductase	epididymis secretory sperm binding protein

Related Diseases

Diseases	Alias
Hyperlysinemia, Type I	Hyperlysinemia Lysine Intolerance Alpha-Aminoadipic Semialdehyde Synthase Deficiency Lysine:Alpha-Ketoglutarate Reductase Deficiency L-Lysine:Nad-Oxido-Reductase Deficiency Lysine Alpha-Ketoglutarate Reductase Deficiency Alpha-Aminoadipic Semialdehyde Deficiency Disease Lysine Alpha-Ketoglutarate Reductase Deficiency Disease Saccharopinuria Hyperlysinemia Type I Hyperlysinemias L-Lysine Nad-Oxido-Reductase Deficiency Familial Hyperlysinemia Saccharopine Dehydrogenase Deficiency Disease Hyperlysinemia, 1 HYPLYS1 Saccharopine Dehydrogenase Deficiency
L-2-Hydroxyglutaric Aciduria	L-2-Hydroxyglutaric Acidemia L2HGA L-2-Hga Aciduria, L-2-Hydroxyglutaric Combined D-2- And L-2-Hydroxyglutaric Aciduria
Epilepsy, Pyridoxine-Dependent	Pyridoxine-Dependent Epilepsy PDE Pyridoxine Dependency With Seizures Vitamin B6-Dependent Seizures EPD Aasa Dehydrogenase Deficiency Antiquitin Deficiency Pyridoxine Dependency Glutamate Decarboxylase Deficiency Pyridoxine-Dependent Seizures Deficiency Of Glutamate Decarboxylase

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-174821	VU439	Modulator	/	Unkown
HY-RS12493	SCCPDH Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	SCCPDH	MGD	MGI:1924486
Rattus norvegicus	SCCPDH	RGD	RGD:1311440
Canis familiaris	SCCPDH	VGNC	VGNC:55761
Macaca mulatta	SCCPDH	VGNC	VGNC:100132
Felis catus	SCCPDH	VGNC	VGNC:107935
Others	SCCPDH	NCBI